Milliman CareFlowIQ transforms fragmented healthcare data into evidence-based insights for informed decision-making

Milliman today announced the launch of CareFlowIQ™, its powerful and scalable clinical intelligence platform, designed to help healthcare providers and health tech leaders make smarter, data-driven decisions. By turning fragmented healthcare data into reliable, evidence-based insights, the platform enables users to uncover patient stories, spot care gaps, and improve outcomes with confidence.

Developed by the data experts at Milliman Pluritem, CareFlowIQ simplifies the chaos of healthcare data. It converts outdated and disconnected records into clean, searchable, and context-rich insights—making it easier to detect medical anomalies, streamline onboarding, and apply advanced analytics to enhance patient outcomes.

“Our team of experienced data specialists and business professionals developed CareFlowIQ, using actual patient records to handle real-world complexity and unlock the full potential of clinical information to be a trusted resource for decision support systems,” says Ben Newton, CEO, Milliman Pluritem. “We deliver more than just clinical data – it’s clinical intelligence, built to deliver the complete patient story. This holistic approach is a major enhancement versus the existing, legacy approaches that struggle to meet the needs of providers and patients in on-site clinics, direct primary care settings, telemedicine visits and self-insured health plans.”

Through a next-generation clinical data pipeline, Milliman CareFlowIQ extracts meaningful narratives from legacy medical records and PDFs, even those previously trapped in clinical notes. It unlocks relevant clinical insights in seconds and supports API integration or direct clinician use. The newly launched, user-friendly website provides visitors with in-depth detail on how the product works and the benefits it offers to providers, patients and healthcare IT teams. For the first time, viewers gain an accurate, clear definition of clinical data, supported by numerous articles highlighting the benefits of clinical data and its favorable comparison to claims data for healthcare decision-making.

“Unlike passive data repositories and outdated tools focused on billing, our clinical intelligence platform is purpose-built, enabling providers to treat patients through evidence-based, powerful clinical insights,” continues Newton. “Built for action, CareFlowIQ’s Whole Patient View™ consolidates and organizes all available records – almost instantaneously – into a single, longitudinal patient profile for truly comprehensive care.”

About Milliman CareFlowIQ

Milliman CareFlowIQ, developed by the experts at Milliman Pluritem, is the superior, scalable clinical data platform that delivers clinical intelligence to healthcare’s data chaos. Through a next-generation clinical data pipeline, CareFlowIQ transforms legacy formats and disconnected records into searchable, clean and context-rich insights. CareFlowIQ enables healthcare providers and health tech leadership to accelerate onboarding, identify care gaps, and make confident, data-driven decisions. Built to handle real-world complexity, CareFlowIQ extracts meaningful narratives from PDFs, even doctor’s notes, to unlock relevant clinical insights in seconds, and support API integration or direct clinician use. It’s not just more clinical data—it’s clinical intelligence built around the complete patient story. Visit us at CareFlowIQ.com.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251007150257/en/